FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119945539> ?p ?o ?g. }

• W3119945539 abstract "Abstract The Netherlands is well known for its early adoption of harm reduction (HR) programs at the height of its heroin crisis in the 1970s/1980s, including the implementation of the first needle and syringe program worldwide. In this manuscript, we describe how the Amsterdam Cohort Studies (ACS) among people who use drugs (PWUD) was conceived within the context of the Dutch HR approach, including the challenges scientists faced while establishing this cohort. This required striking a balance between public health and individual benefit, solving research dilemmas in the face of uncertainty, developing controversial innovative and cutting-edge interventions, which changed the prevention landscape for PWUD, and using longitudinal cohort data to provide unique insights. Studies from the ACS covering follow-up between 1985 and 2016 revealed that participation in both opioid agonist therapy and needle and syringe programs led to a major decrease in the risk of HIV and hepatitis B and C infection acquisition. ACS data have shown that the observed decrease in incidence also likely included shifts in drug markets and drug culture over time, selective mortality among those with the highest levels of risk behaviour, demographic changes of the PWUD population, and progression of the HIV and HCV epidemics. Moreover, HR programs in the Netherlands provided services beyond care for drug use, such as social support and welfare services, likely contributing to its success in curbing the HIV and viral hepatitis epidemics, increasing access and retention to HIV and HCV care and ultimately decreases in overdose mortality over time. Given the low coverage of HR programs in certain regions, it is unsurprising that continued HIV and HCV outbreaks occur and that transmission is ongoing in many countries worldwide. If we aim to reach the World Health Organization viral hepatitis and HIV elimination targets in 2030, as well as to improve the life of PWUD beyond infection risk, comprehensive HR programs need to be integrated as a part of prevention services, as in the Netherlands. We should use the evidence generated by longstanding cohorts, including the ACS, as a basis for which implementation and improved coverage of integrated HR services can be achieved for PWUD worldwide." @default.
• W3119945539 created "2021-01-18" @default.
• W3119945539 creator A5004959902 @default.
• W3119945539 creator A5020731404 @default.
• W3119945539 creator A5045448757 @default.
• W3119945539 creator A5048666386 @default.
• W3119945539 creator A5063856450 @default.
• W3119945539 creator A5079041104 @default.
• W3119945539 date "2021-01-06" @default.
• W3119945539 modified "2023-10-16" @default.
• W3119945539 title "Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective" @default.
• W3119945539 cites W1495940362 @default.
• W3119945539 cites W1531702764 @default.
• W3119945539 cites W1558437381 @default.
• W3119945539 cites W1895966687 @default.
• W3119945539 cites W1978701515 @default.
• W3119945539 cites W1984500779 @default.
• W3119945539 cites W1985301248 @default.
• W3119945539 cites W1986396274 @default.
• W3119945539 cites W1992274556 @default.
• W3119945539 cites W2006118213 @default.
• W3119945539 cites W2007149475 @default.
• W3119945539 cites W2008108229 @default.
• W3119945539 cites W2009228645 @default.
• W3119945539 cites W2010468128 @default.
• W3119945539 cites W2011168956 @default.
• W3119945539 cites W2030028611 @default.
• W3119945539 cites W2030984777 @default.
• W3119945539 cites W2038563025 @default.
• W3119945539 cites W2068185377 @default.
• W3119945539 cites W2071700413 @default.
• W3119945539 cites W2087252539 @default.
• W3119945539 cites W2092239922 @default.
• W3119945539 cites W2093955605 @default.
• W3119945539 cites W2095198714 @default.
• W3119945539 cites W2109639504 @default.
• W3119945539 cites W2122002602 @default.
• W3119945539 cites W2126714813 @default.
• W3119945539 cites W2134206255 @default.
• W3119945539 cites W2144371049 @default.
• W3119945539 cites W2152088367 @default.
• W3119945539 cites W2152872602 @default.
• W3119945539 cites W2164227241 @default.
• W3119945539 cites W2167241049 @default.
• W3119945539 cites W2169626785 @default.
• W3119945539 cites W2256147900 @default.
• W3119945539 cites W2320109282 @default.
• W3119945539 cites W2327835588 @default.
• W3119945539 cites W2753609137 @default.
• W3119945539 cites W2765091655 @default.
• W3119945539 cites W2804237879 @default.
• W3119945539 cites W2939292838 @default.
• W3119945539 cites W2969815372 @default.
• W3119945539 cites W3005951466 @default.
• W3119945539 cites W3020861019 @default.
• W3119945539 cites W3119473535 @default.
• W3119945539 doi "https://doi.org/10.1186/s12954-020-00444-6" @default.
• W3119945539 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7789277" @default.
• W3119945539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33407562" @default.
• W3119945539 hasPublicationYear "2021" @default.
• W3119945539 type Work @default.
• W3119945539 sameAs 3119945539 @default.
• W3119945539 citedByCount "6" @default.
• W3119945539 countsByYear W31199455392021 @default.
• W3119945539 countsByYear W31199455392022 @default.
• W3119945539 countsByYear W31199455392023 @default.
• W3119945539 crossrefType "journal-article" @default.
• W3119945539 hasAuthorship W3119945539A5004959902 @default.
• W3119945539 hasAuthorship W3119945539A5020731404 @default.
• W3119945539 hasAuthorship W3119945539A5045448757 @default.
• W3119945539 hasAuthorship W3119945539A5048666386 @default.
• W3119945539 hasAuthorship W3119945539A5063856450 @default.
• W3119945539 hasAuthorship W3119945539A5079041104 @default.
• W3119945539 hasBestOaLocation W31199455391 @default.
• W3119945539 hasConcept C118552586 @default.
• W3119945539 hasConcept C126322002 @default.
• W3119945539 hasConcept C138816342 @default.
• W3119945539 hasConcept C155164915 @default.
• W3119945539 hasConcept C159110408 @default.
• W3119945539 hasConcept C166957645 @default.
• W3119945539 hasConcept C203014093 @default.
• W3119945539 hasConcept C205649164 @default.
• W3119945539 hasConcept C27415008 @default.
• W3119945539 hasConcept C2776455275 @default.
• W3119945539 hasConcept C2778903686 @default.
• W3119945539 hasConcept C2779343474 @default.
• W3119945539 hasConcept C2780035454 @default.
• W3119945539 hasConcept C2908647359 @default.
• W3119945539 hasConcept C529928208 @default.
• W3119945539 hasConcept C71924100 @default.
• W3119945539 hasConcept C72563966 @default.
• W3119945539 hasConcept C74909509 @default.
• W3119945539 hasConcept C99454951 @default.
• W3119945539 hasConceptScore W3119945539C118552586 @default.
• W3119945539 hasConceptScore W3119945539C126322002 @default.
• W3119945539 hasConceptScore W3119945539C138816342 @default.
• W3119945539 hasConceptScore W3119945539C155164915 @default.
• W3119945539 hasConceptScore W3119945539C159110408 @default.
• W3119945539 hasConceptScore W3119945539C166957645 @default.
• W3119945539 hasConceptScore W3119945539C203014093 @default.

• next